AU2003221272A1 - Use of a nano-copper powder in preparation of the medicaments in preventing and treating of osteoporosis and fracture - Google Patents
Use of a nano-copper powder in preparation of the medicaments in preventing and treating of osteoporosis and fractureInfo
- Publication number
- AU2003221272A1 AU2003221272A1 AU2003221272A AU2003221272A AU2003221272A1 AU 2003221272 A1 AU2003221272 A1 AU 2003221272A1 AU 2003221272 A AU2003221272 A AU 2003221272A AU 2003221272 A AU2003221272 A AU 2003221272A AU 2003221272 A1 AU2003221272 A1 AU 2003221272A1
- Authority
- AU
- Australia
- Prior art keywords
- osteoporosis
- medicaments
- fracture
- nano
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031109551A CN1234371C (en) | 2003-01-28 | 2003-01-28 | Application of nano copper powder for preparing medicine for prophylaxis of osteoporosis and bone fracture |
CN03110955.1 | 2003-01-28 | ||
PCT/CN2003/000099 WO2004067016A1 (en) | 2003-01-28 | 2003-01-29 | Use of a nano-copper powder in preparation of the medicaments in preventing and treating of osteoporosis and fracture |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003221272A1 true AU2003221272A1 (en) | 2004-08-23 |
Family
ID=4790130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003221272A Abandoned AU2003221272A1 (en) | 2003-01-28 | 2003-01-29 | Use of a nano-copper powder in preparation of the medicaments in preventing and treating of osteoporosis and fracture |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1234371C (en) |
AU (1) | AU2003221272A1 (en) |
WO (1) | WO2004067016A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050053673A1 (en) * | 2003-09-05 | 2005-03-10 | Shrirang Netke | Composition and method for facilitating bone healing |
CN112999433B (en) * | 2021-02-23 | 2022-07-05 | 吴江永元生物科技有限公司 | Cu-Zn composite material intrauterine device and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8702254D0 (en) * | 1987-05-29 | 1987-05-29 | Kabivitrum Ab | NOVEL HEPARIN DERIVATIVES |
US5151274A (en) * | 1990-08-06 | 1992-09-29 | The Procter & Gamble Company | Calcium and trace mineral supplements |
CN1065411C (en) * | 1995-06-18 | 2001-05-09 | 侯润安 | Healthful nutrition milk powder and production method |
CN1299678A (en) * | 1999-12-15 | 2001-06-20 | 李全才 | Chinese medicine shennongjingguling |
-
2003
- 2003-01-28 CN CNB031109551A patent/CN1234371C/en not_active Expired - Fee Related
- 2003-01-29 WO PCT/CN2003/000099 patent/WO2004067016A1/en not_active Application Discontinuation
- 2003-01-29 AU AU2003221272A patent/AU2003221272A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1430970A (en) | 2003-07-23 |
WO2004067016A1 (en) | 2004-08-12 |
CN1234371C (en) | 2006-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL213597A0 (en) | Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
IL171683A (en) | Immunosuppressant compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy | |
IL163894A (en) | 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments | |
HUP0400248A3 (en) | Mch antagonists pharmaceutical compositions containing them and their use in the treatment of obesity | |
AU2003264282A1 (en) | Phenethanolamine derivatives and their use in the treatment of respiratory diseases | |
IL164845A (en) | 2-(alpha-hydroxypentyl)benzoate, its preparation, pharmaceutical compositions comprising it and their use in the preparation of medicaments | |
TWI347188B (en) | Treatment and prevention of osteoporosis | |
HK1076110A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
HUP0401174A3 (en) | Ecteinascidin analogues, their use in the preparation of a medicament for treatment of cancer and pharmaceutical compositions containing the compounds | |
IL161744A (en) | Use of zd6474 and taxane in the manufacture of a medicament for the treatment of cancer and pharmaceutical compositions and kits comprising such compounds | |
IL164463A (en) | Use of osteoprotegerin in the preparation of medicaments | |
IL215944A0 (en) | Use of a testosterone comprising pharmaceutical composition in the preparation of medicament for treating or preventing the risk of developing a depressive disorder | |
AU2002323823A1 (en) | Medicament for prevention and treatment of fracture and osteoporosis | |
EP1543841A4 (en) | Soild nano pharmaceutical formulation and preparation method thereof | |
IL172704A (en) | Pharmaceutical composition comprising a salinosporamide compound and use thereof in the manufacture of a medicament for treating cancer | |
PT1525193E (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
HK1074444A1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
GB0615918D0 (en) | Composition and its therapeutic use | |
AU2003207429A1 (en) | Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k | |
AU2002359618A1 (en) | Medicinal compositions and therapeutic methods | |
SI1849468T1 (en) | Pharmaceutical composition comprising roflumilast and levocetirizine | |
AU2003221272A1 (en) | Use of a nano-copper powder in preparation of the medicaments in preventing and treating of osteoporosis and fracture | |
HUP0402061A3 (en) | Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, cox-2 inhibitor and a taxol | |
AU2003271016A1 (en) | Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis | |
AU2003221296A1 (en) | The process for preparation of total coumarins from cortex fraxini and their use in medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |